Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine and dexmedetomidine for emergence agitation after orthognathic surgery
IRCT20130304012695N19Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of diphenhydramine and dexmedetomidine in Emergence agitation (EA) and postoperative pain (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Sedation during tracheal extubation, Postoperative analgesia by visual analog scale and 1 more. Started May 2024; status: completed.
02
Drugs
diphenhydraminedexmedetomidine
03
Conditions
Emergence agitation (EA)postoperative pain
Beyond the preview
Go deeper on IRCT20130304012695N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130304012695N19.